Company: CDLX
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001666071-25-000046
Chunk: 25

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 25
---
 rendered in connection with tax compliance, advice and planning services.

### Pre-Approval Policies and Procedures
The Audit Committee has adopted a pre-approval policy under which the Audit Committee approves in advance all audit and permissible non-audit services to be performed by the independent accountants (subject to a de minimis exception). These services may include audit services, audit-related services, tax services and other non-audit services. As part of its pre-approval policy, the Audit Committee considers whether the provision of any proposed non-audit services is consistent with the SEC's rules on auditor independence. In accordance with its pre-approval policy, the Audit Committee has pre-approved certain specified audit and non-audit services to be provided by our independent auditor. If there are any additional services to be provided, a request for pre-approval must be submitted to the Audit Committee for its consideration under the pre-approval policy. The Audit Committee generally pre-approves particular services or categories of services on a case-by-case basis. Finally, in accordance with the pre-approval policy, the Audit Committee has delegated pre-approval authority to the chair of the Audit Committee. The chair of the Audit Committee must report any pre-approval decisions to the Audit Committee at its next meeting.

All of the services of Deloitte & Touche LLP for 2024 and 2023 described above were pre-approved in accordance with the pre-approval policy adopted by the Audit Committee.

| THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" PROPOSAL NO. 2 |

<div align='center'>19</div>

#### PROPOSAL NO. 3 -

### APPROVAL OF THE EQUITY INCENTIVE PLAN PROPOSAL

### Background
On February 12, 2025, our Board of Directors approved the Cardlytics, Inc. 2025 Equity Incentive Plan (the “2025 Plan”), subject to stockholder approval. Currently, we maintain the Cardlytics, Inc. 2018 Equity Incentive Plan (the “2018 Plan”) to grant stock options, restricted stock unit awards and other stock awards to our employees, consultants and directors. Our Board of Directors adopted, and our stockholders approved, the 2018 Plan in January 2018. Approval of the 2025 Plan by our stockholders will allow us to grant stock options, restricted stock unit awards and other awards and cash-based performance bonus awards at levels determined appropriate by our Board of Directors and Compensation Committee. The 202